(Q67905233)

English

Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol

scientific article published on 01 October 1991

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1836425%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Cholesterol fractions and apolipoproteins during endometriosis treatment by a gonadotrophin releasing hormone (GnRH) agonist implant or by danazol (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1836425%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

based on heuristic

inferred from title

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Jean-Claude Forest

3

object named as

J C Forest

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1836425%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

author name string

A. Lemay

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836425

6 December 2022

N. A. Brideau

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836425

6 December 2022

J. C. Forest

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836425

6 December 2022

S. Dodin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836425

6 December 2022

R. Maheux

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1836425

6 December 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1836425

6 December 2022

publication date

1 October 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1836425%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1991.tb03541.x

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1991.tb03541.x/fullpdf

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1836425%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

35

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1836425%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1836425%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

305-310

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1836425%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Apolipoprotein measurements in clinical biochemistry and their utility vis-a-vis conventional assays

2

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Postmenopausal estrogen use and heart disease risk factors in the 1980s. Rancho Bernardo, Calif, revisited.

3

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Regulation of plasma cholesterol by lipoprotein receptors

4

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Metabolic changes during medical treatment of endometriosis: nafarelin acetate versus danazol

5

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

[Metabolic effects and general side effects in the treatment of endometriosis with an LHRH agonist]

7

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

A comparison of the effects of Buserelin versus danazol on plasma lipoproteins during treatment of pelvic endometriosis

9

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Profound alterations of the lipoprotein metabolism during danazol treatment in premenopausal women

11

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Ovarian suppression in polycystic ovarian disease during 6 month administration of a luteinizing hormone-releasing hormone (LH-RH) agonist

12

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

14

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Clinical appreciation of LHRH analogue formulations

15

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Efficacy of intranasal or subcutaneous luteinizing hormone-releasing hormone agonist inhibition of ovarian function in the treatment of endometriosis

16

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Prevention of follicular maturation in endometriosis by subcutaneous infusion of luteinizing hormone-releasing hormone agonist started in the luteal phase

17

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: a pilot study

19

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Comparison of methods for the measurement of apoproteins A1 and B in serum

21

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity

22

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Free testosterone levels during danazol therapy

23

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Revised American Fertility Society classification of endometriosis: 1985

27

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Comparison between the effects of nafarelin and danazol on serum lipids and lipoproteins in patients with endometriosis

28

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Preliminary endocrinological evaluation of a sustained-release formulation of the LH-releasing hormone agonist D-Ser(But)6Azgly10LHRH in premenopausal women with advanced breast cancer

29

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Suppression of ovarian activity by Zoladex depot (ICI 118630), a long-acting luteinizing hormone releasing hormone agonist analogue

31

1 reference

10.1111/J.1365-2265.1991.TB03541.X

https://api.crossref.org/works/10.1111/J.1365-2265.1991.TB03541.X

6 December 2022

Identifiers

10.1111/J.1365-2265.1991.TB03541.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1836425%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1836425%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67905233&oldid=1785401718"